A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results.
Guilhot, F
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1991 - S26 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
0959-8049
10.1016/0277-5379(91)90561-q doi
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cytarabine--administration & dosage
Female
Humans
Hydroxyurea--administration & dosage
Interferon Type I--administration & dosage
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Middle Aged
Recombinant Proteins
A multicentre study of a randomized therapeutic protocol in previously untreated patients with Ph-positive chronic myelogenous leukaemia: interferon alfa-2b and hydroxyurea with or without cytosine arabinoside , preliminary results. [electronic resource] - European journal of cancer (Oxford, England : 1990) 1991 - S26 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
0959-8049
10.1016/0277-5379(91)90561-q doi
Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cytarabine--administration & dosage
Female
Humans
Hydroxyurea--administration & dosage
Interferon Type I--administration & dosage
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Middle Aged
Recombinant Proteins